Page last updated: 2024-08-26

imipenem, anhydrous and Leukemia, Myeloid, Acute

imipenem, anhydrous has been researched along with Leukemia, Myeloid, Acute in 8 studies

Research

Studies (8)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (12.50)	18.7374
1990's	2 (25.00)	18.2507
2000's	3 (37.50)	29.6817
2010's	1 (12.50)	24.3611
2020's	1 (12.50)	2.80

Authors

Authors	Studies
Hou, JY; Huang, HM; Huang, TH; Liu, HC; Lu, CH; Sun, FJ; Yeh, TC	1
Abubakar, S; Chin, E; Halim, HA; Hanifah, YA; Jaafar, FL; Karunakaran, R; Ng, KP	1
Chien, CC; Kuo, CY; Liu, JW; Tsai, MS; Wang, MC; Wu, HC	1
Argaud, L; Le Scanff, J; Martin, O; Mohammedi, I; Robert, D; Thiebaut, A	1
Arima, H; Hanada, S; Kawahata, H; Makino, T; Nakahara, K; Shimotakahara, S; Takatsuka, Y; Takeuchi, S; Uozumi, K; Utsunomiya, K	1
Bruserud, O	1
Asano, Y; Harada, M; Kozuru, M; Murakawa, M; Niho, Y; Okamura, T; Sawae, Y; Shibuya, T; Taniguchi, S; Toyoshima, T	1
Akasaka, K; Kageyama, T; Kitani, T; Nasu, K; Nin, T; Ohyabu, H; Sannomiya, Y; Tatsumi, N; Tominaga, N; Yonezawa, T	1

Trials

1 trial(s) available for imipenem, anhydrous and Leukemia, Myeloid, Acute

Article	Year
[Therapeutic effects of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group]. The Japanese journal of antibiotics, 1989, Volume: 42, Issue:5 Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma; Male; Middle Aged	1989

Article

Year

[Therapeutic effects of imipenem/cilastatin sodium against severe infections in patients with hematopoietic disorders. Hanshin Infection Study Group].

The Japanese journal of antibiotics, 1989, Volume: 42, Issue:5

Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anti-Bacterial Agents; Bacterial Infections; Cilastatin; Cilastatin, Imipenem Drug Combination; Clinical Trials as Topic; Drug Combinations; Female; Humans; Imipenem; Infusions, Intravenous; Leukemia, Myeloid, Acute; Leukocyte Count; Lymphoma; Male; Middle Aged

1989

Other Studies

7 other study(ies) available for imipenem, anhydrous and Leukemia, Myeloid, Acute

Article	Year
Effectiveness and antimicrobial susceptibility profiles during primary antimicrobial prophylaxis for pediatric acute myeloid leukemia. Scientific reports, 2021, 10-27, Volume: 11, Issue:1 Topics: Anti-Bacterial Agents; Antibiotic Prophylaxis; Antifungal Agents; Bacteremia; Child; Ciprofloxacin; Febrile Neutropenia; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Mycoses; Vancomycin; Voriconazole	2021
Tsukamurella tyrosinosolvens intravascular catheter-related bacteremia in a haematology patient: a case report. European review for medical and pharmacological sciences, 2011, Volume: 15, Issue:11 Topics: Actinomycetales; Actinomycetales Infections; Anti-Bacterial Agents; Bacteremia; Catheter-Related Infections; Catheterization, Central Venous; Female; Humans; Imipenem; Leukemia, Myeloid, Acute; Methicillin-Resistant Staphylococcus aureus; Middle Aged; RNA, Bacterial; RNA, Ribosomal, 16S	2011
Clinical features and risk factors for mortality in Aeromonas bacteremic adults with hematologic malignancies. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi, 2006, Volume: 39, Issue:2 Topics: Aeromonas; Aged; Aged, 80 and over; Antineoplastic Agents; Bacteremia; Consciousness Disorders; Drug Resistance, Bacterial; Female; Fever; Gram-Negative Bacterial Infections; Hematologic Neoplasms; Hospitals; Humans; Imipenem; Leukemia, Myeloid, Acute; Lymphoma, Non-Hodgkin; Male; Middle Aged; Myelodysplastic Syndromes; Piperacillin; Prognosis; Risk Factors; Shock, Septic; Taiwan; Time Factors	2006
Necrotizing gastritis due to Bacillus cereus in an immunocompromised patient. Infection, 2006, Volume: 34, Issue:2 Topics: Adult; Anti-Bacterial Agents; Bacillaceae Infections; Bacillus cereus; Female; Gastritis; Humans; Imipenem; Immunocompromised Host; Leukemia, Myeloid, Acute; Necrosis; Treatment Outcome; Vancomycin	2006
[Acute myelogenous leukemia with spontaneous remission simultaneous with improvement of severe infection: report of 2 cases]. Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine, 1999, Apr-10, Volume: 88, Issue:4 Topics: Abscess; Amikacin; Anti-Bacterial Agents; Anus Diseases; Cellulitis; Cilastatin; Drug Therapy, Combination; Humans; Imipenem; Leukemia, Myeloid, Acute; Male; Middle Aged; Protease Inhibitors; Remission, Spontaneous; Thienamycins	1999
Effects of imipenem and cilastatin on human T-lymphocytes derived from acute leukemia patients with chemotherapy-induced leucopenia: studies of T-lymphocyte responses in the presence of acute myelogenous leukemia (AML) blast accessory cells. International journal of immunopharmacology, 2000, Volume: 22, Issue:1 Topics: Aged; Aged, 80 and over; Antineoplastic Agents; Cilastatin; Cytokines; Dose-Response Relationship, Drug; Female; Humans; Imipenem; Interleukin-2; Leukemia, Myeloid, Acute; Leukopenia; Lymphocyte Activation; Male; Middle Aged; T-Lymphocytes	2000
[Therapeutic evaluation of imipenem/cilastatin sodium for bacterial infections in patients with hematological diseases]. The Japanese journal of antibiotics, 1992, Volume: 45, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Bacterial Infections; Cilastatin; Drug Evaluation; Drug Therapy, Combination; Female; Hematologic Diseases; Humans; Imipenem; Immunocompromised Host; Leukemia, Myeloid, Acute; Male; Middle Aged	1992